ORAGENICS, INC. Cash Equivalents, at Carrying Value
ORAGENICS, INC. (OGEN) had Cash Equivalents, at Carrying Value of $3.90 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash Equivalents, at Carrying Value $3.90M.
- 2026-03-31: Cash Equivalents, at Carrying Value $6.10M.
- 2025-09-30: Cash Equivalents, at Carrying Value $11.40M.
- 2025-06-30: Cash Equivalents, at Carrying Value $2.00M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $3.90M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.10M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $11.40M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |